Page 81 - Eshre 2018

Fertility Preservation Clinical Outcome According to Age.
OR for SV≥90% for EFP vs. ONCO‐FP= 1.484 (CI95%= 0.876‐2.252); P=0.202
LR Model‐ SV≥90%. Categorized by age
Adj. OR
CI95%
P value
EFP vs ONCO
1.968
(1.121‐3.445)
0.018
≤35 y. vs ≥36y.
1.922
(1.274‐2.900)
0.025
≤30 y. vs >40y.
4.116
(1.566‐10.820)
0.004
31‐35y. vs >40y.
2.746
(1.474‐5.115)
0.001
36‐40y. vs >40y.
1.658
(1.259‐2.778)
0.045
LR‐ SV≥90%. Categorized by Age and Type of Stimulation
OR
CI95%
P value
EFP vs ONCO
1.396
(0.563‐3.460)
0.472
≤30 y. vs >40y.
3.942
(1.423‐10.918)
0.008
31‐35y. vs >40y.
2.603
(1.368‐4.953)
0.004
36‐40y. vs >40y.
1.696
(1.099‐2.906)
0.045
Agonist vs Antagonist
1.506
(0.582‐3.895)
0.398
Letrozole vs Antagonist
2.546
(0.840‐7.718)
0.099
Clomiphene vs Antagonist
1.455
(0.508‐4.169)
0.485
Page 75 of 135
IVI unpublished data
Effect of Age and Indication on CLBR
OR for CLBR for EFP vs. ONCO‐FP= 1.275 (CI95%= 0.711‐2.284); P=0.414
LR Model‐ CLBR. Categorized by age
Adj. OR
CI95%
P value
EFP vs ONCO
2.204
(1.162‐4.183)
0.016
≤35 y. vs ≥36y.
3.106
(2.039‐4.733)
<0.0001
≤30 y. vs >40y.
36.477
(9.847‐135.132)
<0.0001
31‐35y. vs >40y.
16.514
(5.581‐48.863)
<0.0001
36‐40y. vs >40y.
7.411
(2.640‐20.804)
<0.0001
LR‐ CLBR Categorized by Age and Type of Stimulation
OR
CI95%
P value
EFP vs ONCO
2.648
(0.949‐7.390)
0.063
≤30 y. vs >40y.
37.261
(8.790‐157.941)
<0.0001
31‐35y. vs >40y.
19.010
(5.564‐64.957)
<0.0001
36‐40y. vs >40y.
9.252
(2.838‐30.159)
<0.0001
Agonist vs Antagonist
1.109
(0.576‐2.134)
0.757
Letrozole vs Antagonist
0.524
(0.277‐1.001
0.051
Clomiphene vs Antagonist
1.120
(0.383‐3.273)
0.836
IVI unpublished data
PRECONGRESS COURSE 16 I BARCELONA, SPAIN – 1 JULY 2018 81